Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LR6TSNRAGREENX4 (U.S. Pat. App. Jan. 9, 2024)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LR6TSNRAGREENX4 (U.S. Pat. App. Jan. 9, 2024)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LR6TSPAYREENX12 (U.S. Pat. App. Jan. 9, 2024)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LR6TSPAYREENX12 (U.S. Pat. App. Jan. 9, 2024)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEONJUWGGREENX3 (U.S. Pat. App. Feb. 28, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEONJUWGGREENX3 (U.S. Pat. App. Feb. 28, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LNYS8HNRXBLUEX4 (U.S. Pat. App. Oct. 20, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LNYS8HNRXBLUEX4 (U.S. Pat. App. Oct. 20, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LM92V5YKGREENX4 (U.S. Pat. App. Sep. 12, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LM92V5YKGREENX4 (U.S. Pat. App. Sep. 12, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LKJGS8H2GREENX4 (U.S. Pat. App. Jul. 25, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LKJGS8H2GREENX4 (U.S. Pat. App. Jul. 25, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LKJGS8GVGREENX4 (U.S. Pat. App. Jul. 25, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LKJGS8GVGREENX4 (U.S. Pat. App. Jul. 25, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. L6E7IV84GREENX4 (U.S. Pat. App. Aug. 3, 2022)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. L6E7IV84GREENX4 (U.S. Pat. App. Aug. 3, 2022)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LFJXDRX8XBLUEX3 (U.S. Pat. App. Mar. 22, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LFJXDRX8XBLUEX3 (U.S. Pat. App. Mar. 22, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LFJVWI4QXBLUEX3 (U.S. Pat. App. Mar. 22, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LFJVWI4QXBLUEX3 (U.S. Pat. App. Mar. 22, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. L5IEJL7WGREENX5 (U.S. Pat. App. Jul. 12, 2022)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. L5IEJL7WGREENX5 (U.S. Pat. App. Jul. 12, 2022)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEX86Z0YXBLUEX1 (U.S. Pat. App. Mar. 7, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEX86Z0YXBLUEX1 (U.S. Pat. App. Mar. 7, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEX86YDQXBLUEX0 (U.S. Pat. App. Mar. 7, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEX86YDQXBLUEX0 (U.S. Pat. App. Mar. 7, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEONJUWJGREENX3 (U.S. Pat. App. Feb. 28, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEONJUWJGREENX3 (U.S. Pat. App. Feb. 28, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEONJUWIGREENX3 (U.S. Pat. App. Feb. 28, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LEONJUWIGREENX3 (U.S. Pat. App. Feb. 28, 2023)
+ More Snippets